International patterns and trends in endometrial cancer incidence, 1978-2013

Journal of the National Cancer Institute

Volumn 110, Issue 4, 2018, Pages 354-361

  Lortet Tieulent, Joannie ^a,b   Ferlay, Jacques ^a,b   Bray, Freddie ^a,b   Jemal, Ahmedin ^a,b  

^a Surveillance and Health Services Research   (Gabon)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BELARUS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; COHORT ANALYSIS; COSTA RICA; ENDOMETRIUM CANCER; FEMALE; HUMAN; INDIA; JAPAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MIDDLE INCOME COUNTRY; NEW ZEALAND; NORTH AMERICA; PHILIPPINES; POSTMENOPAUSE; PRIORITY JOURNAL; SINGAPORE; SLOVAKIA; SOUTH AFRICA; AGE; AGED; CROSS-SECTIONAL STUDY; ENDOMETRIUM TUMOR; FOLLOW UP; GLOBAL HEALTH; INCIDENCE; INTERNATIONAL COOPERATION; PROGNOSIS; REGISTER; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLOBAL HEALTH; HUMANS; INCIDENCE; INTERNATIONAL AGENCIES; MIDDLE AGED; PROGNOSIS; REGISTRIES; RISK FACTORS;

EID: 85052517490     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djx214     Document Type: Article

References (47)

1. American Cancer Society. Cancer Facts & Figures 2016. Atlanta, GA: American Cancer Society; 2016.
2. Arnold M, Karim-Kos HE, Coebergh JW, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. Eur J Cancer. 2015;51(9):1164-1187.
3. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013.
4. Hopkins BD, Goncalves MD, Cantley LC. Obesity and cancer mechanisms: Cancer metabolism. J Clin Oncol. 2016;34(35):4277-4283.
5. Prat J, Franceschi S, Denny L, et al. Endometrial cancer. In: Steward BW, Wild CP, eds. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer; 2014:465-481.
6. Leslie KK, Thiel KW, Goodheart MJ, et al. Endometrial cancer. Obstet Gynecol Clin North Am. 2012;39(2):255-268.
7. Bevier M, Sundquist J, Hemminki K. Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer? Eur J Cancer. 2011;47(4):586-591.
8. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Porgress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
9. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557-567.
10. Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: A population-based study. Lancet Oncol. 2015; 16(1):36-46.
11. Bray F, Dos Santos Silva I, Moller H, et al. Endometrial cancer incidence trends in Europe: Underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev. 2005;14(5):1132-1142.
12. Ferlay J, Bray F, Steliarova-Foucher E, et al. Cancer Incidence in Five Continents, CI5plus. IARC CancerBase No. 9. Lyon, France: International Agency for Research on Cancer; 2014.
13. Statistical Research and Applications Branch, National Cancer Institute. Joinpoint Regression Program. 4.5.0.1 ed. 2017. https://surveillance.cancer.gov/joinpoint/. Accessed October 9, 2017.
14. Clegg LX, Hankey BF, Tiwari R, et al. Estimating average annual percent change in trend analysis. Stat Med. 2009;28(29):3670-3678.
15. StataCorp LP. Stata. 13.1 ed. College Station, TX: StataCorp LP; 2016.
16. Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2296-2302.
17. Lundberg V, Tolonen H, Stegmayr B, et al. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. Maturitas. 2004; 48(1):39-49.
18. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-333.
19. Beral V, Bull D, Reeves G, et al. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2005;365(9470): 1543-1551.
20. Verkooijen HM, Bouchardy C, Vinh-Hung V, et al. The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence. Maturitas. 2009;64(2):80-85.
21. Doepke M. Accounting for Fertility decline during the transition to growth. J Econ Growth. 2004;9(3):347-383.
22. United Nations, Department of Economic and Social Affairs Population Division. World population prospects: The 2015 revision, custom data acquired via website. 2015. https://esa.un.org/unpd/wpp/Download/Standard/Population/. Accessed October 9, 2017.
23. United Nations, Department of Economic and Social Affairs Population Division. World fertility report 2013: Fertility at the extremes. 2014. http://www.un.org/en/development/desa/population/publications/pdf/fertility/worldFertilityReport2013.pdf. Accessed October 9, 2017.
24. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384(9945):766-781.
25. Onstad MA, Schmandt RE, Lu KH. Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol. 2016;34(35): 4225-4230.
26. World Cancer Research Fund International. Cancer preventability estimates for diet, nutrition, body fatness, and physical activity. http://www.wcrf.org/int/cancer-facts-figures/preventability-estimates/cancer-preventability-esti mates-diet-nutrition. Accessed October 9, 2017.
27. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington, DC: American Institute for Cancer Research; 2007.
28. Aguiree F, Brown A, Cho NH, et al. IDF Diabetes Atlas. 6th ed. Basel, Switzerland: International Diabetes Federation; 2013.
29. World Health Organization. Global Status Report on Noncommunicable Diseases 2014. Geneva, Switzerland: World Health Organization; 2014. http://www.who.int/nmh/publications/ncd-status-report-2014/en/. Accessed October 9, 2017.
30. Lortet-Tieulent J, Renteria E, Sharp L, et al. Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988-2010. Eur J Cancer. 2015;51(9):1144-1163.
31. Collaborative Group on Epidemiological Studies on Endometrial Cancer. Endometrial cancer and oral contraceptives: An individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. Lancet Oncol. 2015;16(9):1061-1070.
32. Darroch JE, Singh S. Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: An analysis of national surveys. Lancet. 2013;381(9879):1756-1762.
33. Felix AS, Gaudet MM, La Vecchia C, et al. Intrauterine devices and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer Consortium. Int J Cancer. 2015;136(5):E410-E422.
34. Setiawan VW, Yang HP, Pike MC, et al. Type I and II endometrial cancers: Have they different risk factors? J Clin Oncol. 2013;31(20):2607-2618.
35. Weiderpass E, Antoine J, Bray FI, et al. Trends in corpus uteri cancer mortality in member states of the European Union. Eur J Cancer. 2014;50(9):1675-1684.
36. Bray F, Loos AH, Oostindier M, et al. Geographic and temporal variations in cancer of the corpus uteri: Incidence and mortality in pre- and postmenopausal women in Europe. Int J Cancer. 2005;117(1):123-131.
37. Lindemann K, Eskild A, Vatten LJ, et al. Endometrial cancer incidence trends in Norway during 1953-2007 and predictions for 2008-2027. Int J Cancer. 2010; 127(11):2661-2668.
38. Chakalova G, Dimitrova N, Gavrilov I, et al. Cancer burden of breast and gynecological cancers in Bulgaria: Epidemiology and clinical aspects. J BUON. 2013;18(4):1038-1044.
39. Milas J, Samardzic S, Milas K. Malignant neoplasms of breast and female genital organs (C50, C51-C58) in the Osijek-Baranja County, Croatia. Coll Antropol. 2014;38(4):1135-1151.
40. Jamison PM, Noone AM, Ries LA, et al. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev. 2013;22(2):233-241.
41. Yeole BB. Trends in cancer incidence in female breast, cervix uteri, corpus uteri, and ovary in India. Asian Pac J Cancer Prev. 2008;9(1):119-122.
42. Murthy NS, Shalini S, Sastry NB, et al. Increase in incidence of cancer of corpus uteri: Estimation of time trends - an Indian scenario. Eur J Cancer Prev. 2011;20(1):25-32.
43. Alghamdi IG, Hussain, II, Alghamdi MS, et al. The incidence rate of corpus uteri cancer among females in Saudi Arabia: An observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001-2008. Int J Womens Health. 2014;6:141-147.
44. Hammer A, Rositch AF, Kahlert J, et al. Global epidemiology of hysterectomy: Possible impact on gynecological cancer rates. Am J Obstet Gynecol. 2015; 213(1):23-29.
45. OECD. Stat Health. Health care utilisation: Surgical procedures. https://stats.oecd.org/index.aspx?DataSetCode¼HEALTH_STAT#. Accessed October 9, 2017.
46. Siegel RL, Devesa SS, Cokkinides V, et al. State-level uterine corpus cancer incidence rates corrected for hysterectomy prevalence, 2004 to 2008. Cancer Epidemiol Biomarkers Prev. 2013;22(1):25-31.
47. Luoto R, Raitanen J, Pukkala E, et al. Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010. Br J Cancer. 2004;90(9):1756-1759.